The clinical practice of palliative sedation in patients dying from COVID-19: a retrospective chart review

[1] Talukder A(2022)Association between symptoms and severity of Disease in Hospitalised Novel Coronavirus (COVID-19) patients: a systematic review and Meta-analysis J Multidiscip Healthc 15 1101-10

[2] Razu SR(2020)Characteristics, Symptom Management, and outcomes of 101 patients with COVID-19 referred for Hospital Palliative Care J Pain Symptom Manage 60 e77-e81

[3] Alif SM(2020)An audit of end-of-life symptom control in patients with corona virus disease 2019 (COVID-19) dying in a hospital in the United Kingdom Palliat Med 34 1249-55

[4] Rahman MA(2009)European Association for Palliative Care (EAPC) recommended framework for the use of sedation in palliative care Palliat Med 23 581-93

[5] Islam SMS(2013)Recommendations for managing missing data, attrition and response shift in palliative and end-of-life care research: part of the MORECare research method guidance on statistical issues Palliat Med 27 899-907

[6] Lovell N(2020)COVID-19 and Hospital Palliative Care - A service evaluation exploring the symptoms and outcomes of 186 patients and the impact of the pandemic on specialist Hospital Palliative Care Palliat Med 34 1256-62

[7] Maddocks M(2022)The prevalence of Palliative Care Consultation in deceased COVID-19 patients and its association with end-of-Life Care J Palliat Med 25 70-4

[8] Etkind SN(2021)Clinical aspects of Palliative Sedation in prospective studies. A systematic review J Pain Symptom Manage 61 831-44

[9] Alderman B(2021)Development and validation of a prediction model for 30-day mortality in hospitalised patients with COVID-19: the COVID-19 SEIMC score Thorax 76 920-9

[10] Webber K(2021)Patients with terminal interstitial pneumonia require comparable or more palliative pharmacotherapy for refractory dyspnea than patients with terminal Lung Cancer Palliat Med Rep 2 188-93

[1] Talukder A(2022)Association between symptoms and severity of Disease in Hospitalised Novel Coronavirus (COVID-19) patients: a systematic review and Meta-analysis J Multidiscip Healthc 15 1101-10

[2] Razu SR(2020)Characteristics, Symptom Management, and outcomes of 101 patients with COVID-19 referred for Hospital Palliative Care J Pain Symptom Manage 60 e77-e81

[3] Alif SM(2020)An audit of end-of-life symptom control in patients with corona virus disease 2019 (COVID-19) dying in a hospital in the United Kingdom Palliat Med 34 1249-55

[4] Rahman MA(2009)European Association for Palliative Care (EAPC) recommended framework for the use of sedation in palliative care Palliat Med 23 581-93

[5] Islam SMS(2013)Recommendations for managing missing data, attrition and response shift in palliative and end-of-life care research: part of the MORECare research method guidance on statistical issues Palliat Med 27 899-907

[6] Lovell N(2020)COVID-19 and Hospital Palliative Care - A service evaluation exploring the symptoms and outcomes of 186 patients and the impact of the pandemic on specialist Hospital Palliative Care Palliat Med 34 1256-62

[7] Maddocks M(2022)The prevalence of Palliative Care Consultation in deceased COVID-19 patients and its association with end-of-Life Care J Palliat Med 25 70-4

[8] Etkind SN(2021)Clinical aspects of Palliative Sedation in prospective studies. A systematic review J Pain Symptom Manage 61 831-44

[9] Alderman B(2021)Development and validation of a prediction model for 30-day mortality in hospitalised patients with COVID-19: the COVID-19 SEIMC score Thorax 76 920-9

[10] Webber K(2021)Patients with terminal interstitial pneumonia require comparable or more palliative pharmacotherapy for refractory dyspnea than patients with terminal Lung Cancer Palliat Med Rep 2 188-93